Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II open-label study of JFAN-1001 mesylate capsules in advanced or metastatic non-squamous EGFR-mutant non-small cell lung cancer
CTR20251815Phase 2Active
- Sponsor
- Jianfeng Yien Biotech
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of JFAN-1001 in Non-small cell lung cancer (NS-NSCLC), sponsored by Jianfeng Yien Biotech. Started May 2025; status: active.
02
Drugs
JFAN-1001
03
Conditions
Non-small cell lung cancer (NS-NSCLC)
Beyond the preview
Go deeper on CTR20251815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251815.